TABLE 3.
Variables | Cases (n = 37) | Controls (n = 89) | p |
---|---|---|---|
Documented clearance of candidaemia within 3 days after initiation of antifungal therapya | 19/30 (63) | 48/57 (84) | 0.035 |
Treatment failure at 2 weeks | 25 (68) | 55 (62) | 0.55 |
Clinical failureb | 5 (14) | 13 (15) | 1.00 |
Microbiological failurec | 5 (14) | 5 (6) | 0.16 |
Death | 15 (41) | 37 (42) | 1.00 |
Mortality at 6 weeks | |||
Crude | 24 (65) | 50 (56) | 0.43 |
Candidaemia-attributable | 16 (43) | 37 (42) | 1.00 |
Data are no. (%) of patients, unless otherwise indicated.
Data are event/evaluable no. (%) of patients.
Worsening or no improvement of attributable symptoms or signs of candidaemia.
Persistent isolation of Candida species from blood specimens at 2 weeks.